Wedbush Reiterates Neutral on Vera Therapeutics, Maintains $34 Price Target

Benzinga Newsdesk www.benzinga.com Neutral 90.1%

Neg 0% Neu 90.1% Pos 0%

Wedbush analyst Laura Chico reiterates Vera Therapeutics (NASDAQ:VERA) with a Neutral and maintains $34 price target.

Comments

No comments yet. Be the first!